City of Hope Joins OncLive's Strategic Alliance Partnership Program

City of Hope teams with OncLive to further promote its distinctions and innovations in cancer care. As a member of OncLive's Strategic Partnership program, City of Hope will have the opportunity to promote its state-of-the-art comprehensive cancer center and the center's latest scientific discoveries, treatment and prevention strategies.

PLAINSBORO, N.J. -- October 17, 2014 -- OncLive® is pleased to announce that City of Hope has joined its Strategic Alliance Partnership program.

As a member of OncLive’s Strategic Partnership program, City of Hope will have the opportunity to promote its state-of-the-art comprehensive cancer center and the center’s latest scientific discoveries, treatment and prevention strategies.

City of Hope, a National Cancer Institute-designated Comprehensive Cancer Center, is a leading research and treatment center for cancer and other life-threatening diseases. For 11 years, City of Hope has been recognized by US News & World Report as one of the top cancer hospitals in the nation. The center’s role as a leader in patient care, basic and clinical research, and the translation of science into tangible benefit is widely acknowledged.

Currently, City of Hope has more than 200 patents and 29 investigational new drug applications. Some of today’s top cancer drugs are based on technology developed developed by City of Hope researchers.

Mike Hennessy, Jr., Vice President of Sales and Marketing and leader of the oncology division of Intellisphere, the publisher of OncLive, said, “We are excited to partner with City of Hope. The initiatives of City of Hope have paved a path in cancer care and other life-threatening diseases, and we are excited to learn about and share their future findings with health care professionals.”

To date, more than 20 cancer centers, nursing schools, and other groups have joined OncLive’s Strategic Alliance Partnership program.

To learn more about OncLive®, visit http://www.OncLive.com.

###

About OncLive®

OncLive.com is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary Oncology. The mission of OncLive® and its family of publications is to provide oncology professionals with the resources and information they need in order to provide the best care for their patients. The Oncology Specialty Group is a division of Intellisphere, LLC, a leading provider of health care publishing, research, and education. To learn more, please visit http://www.OncLive.com.

About City of Hope

City of Hope is a leading research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope’s main hospital is located in Duarte, Calif., just northeast of Los Angeles, with clinics in Antelope Valley and South Pasadena. It is ranked as one of "America's Best Hospitals" in cancer by U.S.News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. For more information, visit http://www.cityofhope.org or follow City of Hope on facebook, twitter, YouTube or flickr.